Economy · 9 sources
Centre To Cap Trade Margins At 30 Per Cent Of MRP For 110 Anti-Cancer Drugs, Including 35 Patented Medicines
Coverage by lean
33% Lean Left56% Centre11% Lean Right
Left 3
Centre 5
Right 1
Centre to cap trade margins on non-scheduled cancer drugs at 30%Business Standard
One headline per side, the first Trikon holds. Every outlet is listed below.
Left · 3
The Hindu · Lean Left
Centre to cap trade margins on non-scheduled cancer drugs to 30% of MRP
◈ Kasturi & Sons Ltd, The Hindu Group
New Indian Express · Lean Left
Cancer drugs to get 70% cheaper as centre plans to cap trade margins
◈ Express Publications (Madurai), Manoj Kumar Sonthalia
The Morung Express · Lean Left
Prices of 110 anti-cancer medicines may fall up to 70 pc as govt caps trade margins
◈ Aküm Longchari and founding collective; board-run
Centre · 5
The Tribune · Centre
Centre to cap trade margins at 30% for non-scheduled cancer drugs
◈ The Tribune Trust
The Shillong Times · Centre
Prices of 110 anti-cancer medicines may fall up to 70 pc as govt caps trade margins
◈ Shillong Times Pvt Ltd, Chaudhuri family
The Hans India · Centre
Prices of 110 anti-cancer medicines may fall up to 70 pc as govt caps trade margins
◈ Hyderabad Media House Ltd; Kapil Group (K. Vaman Rao)
Sambad English · Centre
Prices of 110 anti-cancer medicines may fall up to 70 pc as govt caps trade margins
◈ Soumya Ranjan Patnaik, founder-owner; Sambad Group
Free Press Journal · Centre
Centre To Cap Trade Margins At 30 Per Cent Of MRP For 110 Anti-Cancer Drugs, Including 35 Patented Medicines
◈ Indian National Press (Bombay), Karnani family
Right · 1
Business Standard · Lean Right
Centre to cap trade margins on non-scheduled cancer drugs at 30%
◈ Business Standard Pvt Ltd (Kotak family, Uday Kotak)
Verify with IFCN fact-checkers →Vishvas NewsIFCN ↗NewsCheckerIFCN ↗Fact CrescendoIFCN ↗Alt NewsIFCN ↗Google Fact Check ↗